Patterns of antituberculous drug resistance in Eastern Saudi Arabia: a 7-year surveillance study from 1/2003 to 6/2010

J Epidemiol Glob Health. 2012 Mar;2(1):57-60. doi: 10.1016/j.jegh.2011.10.001. Epub 2011 Dec 24.

Abstract

Objective: To examine the patterns of antituberculous drug resistance of Mycobacterium tuberculosis in patients with pulmonary and extra-pulmonary tuberculosis in the Eastern province of the Kingdom of Saudi Arabia.

Methods: This is a retrospective study of antibiotic susceptibility of 1681 non-repetitive M. tuberculosis isolates from 1/2003 to 6/2010.

Results: Of the total patients, 41% (n=687) were Saudis and 59% (n=994) were non-Saudis. The pulmonary and extra-pulmonary specimens constituted 68% (n=1148) and 32% (n=533), respectively. The incidence of resistance was 15.5% to one or more of anti-tuberculosis drugs. The resistance rates to first-line drugs were as follows: streptomycin (10.4%), INH (9.8%), rifampicin (1.5%) and ethambutol (1.0%). Multi-drug resistant tuberculosis was present in 1.4% (n=24) of the sample.

Conclusion: INH resistance in this study was relatively high, whereas the rate of MDR-TB was low. A rate of MDR-TB observed in this study was 1.4%. Thus, an empiric four-drug therapy is required to treat patients with tuberculosis in this area of Saudi Arabia.

Keywords: DST; Eastern Saudi Arabia; Incidence; MDR-TB; NTBCP; Prevalence; Resistance; SDR-TB; Tuberculosis; drug sensitivity test; multi-drug resistance tuberculosis; national tuberculosis control program; single drug resistance tuberculosis.

MeSH terms

  • Adult
  • Antitubercular Agents / pharmacology*
  • Antitubercular Agents / therapeutic use
  • Cohort Studies
  • Developing Countries
  • Drug Resistance, Bacterial*
  • Female
  • Health Surveys
  • Humans
  • Incidence
  • Microbial Sensitivity Tests
  • Middle Aged
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / isolation & purification
  • Retrospective Studies
  • Risk Assessment
  • Saudi Arabia / epidemiology
  • Tuberculosis / diagnosis
  • Tuberculosis / drug therapy*
  • Tuberculosis / epidemiology
  • Tuberculosis, Multidrug-Resistant / epidemiology*

Substances

  • Antitubercular Agents